118 related articles for article (PubMed ID: 8327566)
1. [The pharmacokinetics of Z-2-amino-5-chlorobenzophenoneamidinohydrazone in the rat].
Schieweck A; offchert HH; Morgenroth U; Joram U
Pharmazie; 1993 May; 48(5):370-3. PubMed ID: 8327566
[TBL] [Abstract][Full Text] [Related]
2. [Biotransformation and excretion of Z-2-amino-5-chlorobenzophenoneamidinohydrazone].
Borchert HH; Schieweck A; Franke P; Morgenroth U; Joram U
Pharmazie; 1993 May; 48(5):365-70. PubMed ID: 8327565
[TBL] [Abstract][Full Text] [Related]
3. [The pharmacokinetics of a new anti-arrhythmic substance, Z-2-amino-5-chlorobenzophenoneamidinohydrazone (AWD-G256)].
Farker K; Henschel L; Marschner JP; Reimann I; Volkmann H; Hoffmann A
Pharmazie; 1993 May; 48(5):373-80. PubMed ID: 8327567
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
Okuyama Y; Momota K; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetics and metabolite pattern of clenbuterol in the rat].
Kopitar Z; Zimmer A
Arzneimittelforschung; 1976; 26(7a):1435-41. PubMed ID: 1036935
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and metabolism of the antiarrhythmic agent [3H]-diprafenone in the rat.
Brunner F; Kolmayr U; Kukovetz WR
Arzneimittelforschung; 1989 Nov; 39(11):1430-5. PubMed ID: 2619776
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
[TBL] [Abstract][Full Text] [Related]
9. Effect of ciprofloxacin on the disposition of 14C-dideoxyinosine-derived radioactivity in the rat.
Gallicano KD; Buttar HS; Moffatt JH
Res Commun Chem Pathol Pharmacol; 1993 May; 80(2):163-74. PubMed ID: 8321920
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
[TBL] [Abstract][Full Text] [Related]
11. Distribution of [14C]-tofenacine in rat brain after intravenous, intraperitoneal and multiple oral dosage.
Hespe W; Beem J
Arzneimittelforschung; 1975; 25(12):1910-5. PubMed ID: 1243662
[TBL] [Abstract][Full Text] [Related]
12. [Studies on the pharmacokinetics and biotransformation of ipratropium bromide in the rat and dog].
Förster HJ; Kramer I; Pook KH; Wahl D
Arzneimittelforschung; 1976; 26(5a):992-1005. PubMed ID: 134731
[TBL] [Abstract][Full Text] [Related]
13. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of 14C-moxisylyte in hairless rat. Comparison between intravenous and oral route.
Neau B; Roux J; Lambrey B; Courtiol C; Marty JP; Grislain L
Arzneimittelforschung; 1995 Jan; 45(1):10-4. PubMed ID: 7893260
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics study of 14C-moxisylyte after percutaneous application to hairless rat.
Neau B; Roux J; Courtiol C; Lambrey B; Marty JP
Arzneimittelforschung; 1995 Nov; 45(11):1161-5. PubMed ID: 8929231
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of YM175, a new bisphosphonate, in rats and dogs.
Usui T; Watanabe T; Higuchi S
Drug Metab Dispos; 1995 Nov; 23(11):1214-9. PubMed ID: 8591721
[TBL] [Abstract][Full Text] [Related]
17. [The pharmacokinetics of Oral-Turinabol in humans].
Schumann W
Pharmazie; 1991 Sep; 46(9):650-4. PubMed ID: 1798729
[TBL] [Abstract][Full Text] [Related]
18. [The pharmacokinetics of 14C-zolimidine in rats].
Schraven E; Trottnow D
Arzneimittelforschung; 1976 Feb; 26(2):213-8. PubMed ID: 947201
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
[TBL] [Abstract][Full Text] [Related]
20. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
